Ching N. Ou

1.5k total citations · 1 hit paper
9 papers, 1.2k citations indexed

About

Ching N. Ou is a scholar working on Molecular Biology, Surgery and Clinical Biochemistry. According to data from OpenAlex, Ching N. Ou has authored 9 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Surgery and 2 papers in Clinical Biochemistry. Recurrent topics in Ching N. Ou's work include Metabolism and Genetic Disorders (2 papers), Adipose Tissue and Metabolism (1 paper) and Virus-based gene therapy research (1 paper). Ching N. Ou is often cited by papers focused on Metabolism and Genetic Disorders (2 papers), Adipose Tissue and Metabolism (1 paper) and Virus-based gene therapy research (1 paper). Ching N. Ou collaborates with scholars based in United States, Thailand and Canada. Ching N. Ou's co-authors include Milton J. Finegold, Lorna Taylor, Debra Rose Wilson, Allan Bradley, Gretchen J. Darlington, Margaret Wilde, Cheryl L. Rognerud, James Versalovic, Jennifer K. Spinler and Somying Tumwasorn and has published in prestigious journals such as Science, Environmental Health Perspectives and The Journal of Pediatrics.

In The Last Decade

Ching N. Ou

9 papers receiving 1.2k citations

Hit Papers

Impaired Energy Homeostasis in C/EBPα Knockout Mice 1995 2026 2005 2015 1995 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ching N. Ou United States 6 674 266 209 180 172 9 1.2k
R. K. Rao United States 15 649 1.0× 163 0.6× 205 1.0× 164 0.9× 142 0.8× 32 1.3k
Sofia Tedelind Sweden 9 596 0.9× 224 0.8× 86 0.4× 105 0.6× 113 0.7× 9 972
H Lührs Germany 19 878 1.3× 219 0.8× 112 0.5× 247 1.4× 247 1.4× 27 1.6k
Natalia Smirnova France 15 647 1.0× 375 1.4× 194 0.9× 152 0.8× 183 1.1× 22 1.1k
Qihong Zhao United States 14 776 1.2× 218 0.8× 126 0.6× 154 0.9× 190 1.1× 22 1.4k
Stanley Lightfoot United States 17 684 1.0× 189 0.7× 99 0.5× 165 0.9× 124 0.7× 46 1.3k
Shien Hu United States 17 664 1.0× 117 0.4× 84 0.4× 109 0.6× 119 0.7× 25 1.0k
Erik Eckhardt United States 21 860 1.3× 406 1.5× 324 1.6× 461 2.6× 116 0.7× 40 1.8k
Christian Barmeyer Germany 20 845 1.3× 131 0.5× 213 1.0× 417 2.3× 308 1.8× 28 1.7k
Sumeet Pandey United Kingdom 10 649 1.0× 167 0.6× 201 1.0× 77 0.4× 105 0.6× 11 1.1k

Countries citing papers authored by Ching N. Ou

Since Specialization
Citations

This map shows the geographic impact of Ching N. Ou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ching N. Ou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ching N. Ou more than expected).

Fields of papers citing papers by Ching N. Ou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ching N. Ou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ching N. Ou. The network helps show where Ching N. Ou may publish in the future.

Co-authorship network of co-authors of Ching N. Ou

This figure shows the co-authorship network connecting the top 25 collaborators of Ching N. Ou. A scholar is included among the top collaborators of Ching N. Ou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ching N. Ou. Ching N. Ou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Spinler, Jennifer K., Malai Taweechotipatr, Cheryl L. Rognerud, et al.. (2008). Human-derived probiotic Lactobacillus reuteri demonstrate antimicrobial activities targeting diverse enteric bacterial pathogens. Anaerobe. 14(3). 166–171. 257 indexed citations
2.
Agarwal, Neeraj, et al.. (2007). Familial Polycythemia Caused by a Novel Mutation in the Beta Globin Gene: Essential Role of P50 in Evaluation of Familial Polycythemia. International Journal of Medical Sciences. 4(4). 232–236. 18 indexed citations
3.
Lieberman, Michael W., Ernest D. Lykissa, Roberto Barrios, et al.. (1999). Cyclosiloxanes Produce Fatal Liver and Lung Damage in Mice. Environmental Health Perspectives. 107(2). 161–161. 2 indexed citations
4.
Lieberman, Michael W., Roberto Barrios, Geeta Kala, et al.. (1999). Response from Lieberman and Colleagues. Environmental Health Perspectives. 107(9). A444–A444. 1 indexed citations
5.
Shulman, Robert J., et al.. (1998). Central Venous Catheters Versus Peripheral Veins for Sampling Blood Levels of Commonly Used Drugs. Journal of Parenteral and Enteral Nutrition. 22(4). 234–237. 22 indexed citations
6.
Overturf, Ken, Muhsen Al-Dhalimy, Ching N. Ou, et al.. (1997). Adenovirus-Mediated Gene Therapy in a Mouse Model of Hereditary Tyrosinemia Type I. Human Gene Therapy. 8(5). 513–521. 58 indexed citations
7.
Shulman, Robert J., et al.. (1995). Absorption of lactose, glucose polymers, or combination in premature infants. The Journal of Pediatrics. 127(4). 626–631. 35 indexed citations
8.
Finegold, Milton J., Allan Bradley, Ching N. Ou, et al.. (1995). Impaired Energy Homeostasis in C/EBPα Knockout Mice. Science. 269(5227). 1108–1112. 805 indexed citations breakdown →
9.
Goddard‐Finegold, Jan, Claire Langston, Edith P. Hawkins, Lloyd H. Michael, & Ching N. Ou. (1989). Prostaglandin E1 -Associated Pathology of Pulmonary Microvasculature in Newborn Pups: Similarity to Findings in Prostaglandin E1 -Treated Human Newborns. Pediatric Pathology. 9(3). 251–260. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026